Jump to content
Powered by
  • Industry report The healthcare industry – the innovation driver of the 21st century: opportunities and challenges

    BIOPRO Baden-Württemberg’s new industry report entitled "The Healthcare Industry 2018: Facts and Figures for Baden-Württemberg" has just been published in both German and English.

  • Contact Stay in touch

    Would you like continue receiving e-mail notifications about our activities, up-to-date information, events, opportunities for cooperation and general industry information? Register here to stay informed about current issues.

  • Dossier Immunology – at the forefront of medical progress

    Immunological approaches are central to everything – learn more!

  • AI & Pharma AI in the Pharmaceutical Industry

    BIOPRO Baden-Württemberg is organising a two-day event on "Application Potential of Artificial Intelligence in the Pharmaceutical Industry". Save the dates and see you on April 22 and May 6, 2021!


AI application potential & Matchmaking

Online

BIOPRO Baden-Württemberg together with Fraunhofer Institute for Manufacturing Engineering and Automation IPA are organising a two-day event on the topic "Application Potential of Artificial Intelligence in the Pharmaceutical Industry". The event kick-off takes place on 22 April 2021 and is entitled "AI in use in the pharmaceutical industry – day 1". On 6 May 2021, the event continues with "Meet & Match: AI in the pharmaceutical industry – day 2" which is dedicated to networking and matchmaking.

Latest news

  • Quantum Technology Ulm - 08/04/2021

    The world's first commercial quantum computer,’IBM Q System One’, is now in operation in Ehningen near Stuttgart. This is a major leap forward in quantum technology in Germany. It marks the point at which conventional computers reach their limits. The University of Ulm is involved in three of six collaborative projects being funded by the Baden-Württemberg Ministry of Economic Affairs, Labour and Housing Construction.

  • Press release - 24/03/2021

    Tumor vaccines can help the body fight cancer. Mutations in the tumor genome often lead to protein changes that are typical of cancer. A vaccine can alert the patients' immune system to these mutated proteins. For the first time, physicians and cancer researchers from Heidelberg and Mannheim have now carried out a clinical trial to test a mutation-specific vaccine against malignant brain tumors.

  • Press release - 24/03/2021

    Immunotherapy using checkpoint inhibitors is effective in around a quarter of patients with liver cancer. However, to date, physicians have been unable to predict which patients would benefit from this type of treatment and which would not. Researchers from the German Cancer Research Center have now discovered that liver cancer caused by chronic inflammatory fatty liver disease does not respond to this treatment. On the contrary: in an…

  • Microfluidics in medical technology - 24/03/2021

    Karlsruhe-based company memetis shows that this is possible. Intelligent components for controlling fluids open up huge potential in the medical technology and biotechnology sectors - from vaccine development and cell line analysis to drug research and point-of-care solutions.

  • Press release - 23/03/2021

    CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), today announced the publication of preclinical data demonstrating that their COVID-19 vaccine candidate, CVnCoV, protects against challenge infections with the SARS-CoV-2 Variant of Concern B.1.351 and a strain of the original SARS-CoV-2 B1 lineage (BavPat1) in a transgenic mouse model.

Website address: https://www.gesundheitsindustrie-bw.de/en